Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Clinical trial Stories

2014-04-04 08:25:09

REDWOOD CITY, Calif., April 4, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, and Timothy E. Morris, CFO, will present a Company update on April 9(th). Presentation details are as follows: 13(th) Annual Needham Healthcare Conference Date: Wednesday,...

2014-04-03 08:28:44

Company Noted for Quality and On Time Delivery RESEARCH TRIANGLE PARK, N.C., April 3, 2014 /PRNewswire/ -- Marken announced today the completion of an industry wide, independent market research study. The survey included 250 key decision makers of clinical trial logistics services from pharmaceutical companies, central laboratories, clinical research organizations and manufacturing service providers in North America, Central & South America, Europe, and Asia. Key topics profiled...

2014-04-02 23:25:23

The new Clinical Conductor CTMS brings enhanced collaborative and financial functionality that make it the most comprehensive CTMS available. Rochester, NY (PRWEB) April 02, 2014 The new Clinical Conductor CTMS is here, and with it comes a revolution in clinical trial collaboration. The industry’s only true collaborative CTMS takes this capability to a new level. The leading financial capabilities of Clinical Conductor have also been strengthened in this release and provide users...

2014-04-02 20:21:59

Dr. Mark W Jacobson also strengthens clinical team. LAMBERTVILLE, N.J., April 2, 2014 /PRNewswire/ -- CROnos Clinical Consulting, a global neuroscience focused clinical data quality control organization (QCO) with proven processes for delivering results, announced today that Dr. Nina Engelhardt has joined the Company as Vice President, Scientific Innovation. Dr. Engelhardt has been actively involved in innovations in trial methodology and clinical assessment to increase the success...

2014-04-02 08:33:12

Regulatory Clearance Enables Commercialization in Europe and other Key Markets GREENWOOD VILLAGE, Colo., April 2, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc., (NYSE MKT: AMPE) today announced that its subsidiary Luoxis, an in vitro diagnostics company, has obtained CE Marking in Europe for its RedoxSYS(TM) Diagnostic System, the company's blood-based platform for assessing the level of oxidative stress in the body. This regulatory clearance allows Luoxis to engage in strategic...

2014-04-01 23:23:16

Professionals from across East Asia will discuss the latest hot topics in all stages of drug development at the 8th DIA Annual Conference in Japan for Asian New Drug Development. Tokyo, Japan (PRWEB) April 01, 2014 Professionals from across East Asia will discuss the latest hot topics in all stages of drug development at the 8th DIA Annual Conference in Japan for Asian New Drug Development. The event will return for its eighth year on May 22 to 23, at Sola City Hall, Ochanomizu in Tokyo....

2014-04-01 23:03:13

Clinical Trial Magnifier Weekly monitors 150,000 trials in 185 countries around the world every week and reports all the fresh changes. Subscribers are able to scan all the changes and drill down using links in the newsletter to focus on the ones that are important, saving them countless hours of effort. Falls Church, VA (PRWEB) April 01, 2014 Clinical Trial Magnifier Weekly http://www.fdanews.com/CTM FDAnews is proud to announce the release of Clinical Trial Magnifier Weekly. Clinical...

2014-04-01 08:30:29

Webinar to Explore Cutting-Edge Use of Data Analytics that Challenges Traditional Approach to Feasibility Studies and Significantly Increases Predictability BURLINGTON, Mass., April 1, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to accelerate trials efficiently and predictably, will discuss the latest innovations in trial feasibility during a webinar next week hosted by Clinical Informatics News. Otis Johnson, executive director of...

2014-04-01 08:28:50

New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients BRIDGEWATER, N.J. and TARRYTOWN, N.Y., April 1, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the first Phase 2 study with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), in Japanese patients met its primary endpoint. The results...

2014-04-01 08:28:44

SAN DIEGO, April 1, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that clinical data from a study using the company's cancer monitoring platform for the detection and longitudinal monitoring of BRAF V600E mutations will be the subject of a late-breaking poster presentation at the American Association for Cancer Research Annual Meeting in San Diego, California....